The oxidant stress of hyperhomocyst(e)inemia.

[1]  C. Sobey,et al.  Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[2]  W. Vermaak,et al.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism. , 1996, The Journal of clinical investigation.

[3]  J. Loscalzo,et al.  Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. , 1996, The Journal of clinical investigation.

[4]  J. Loscalzo,et al.  Homocyst(e)ine decreases cell redox potential in vascular smooth muscle cells , 1996 .

[5]  H. Blom,et al.  Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease , 1995, European journal of clinical investigation.

[6]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[8]  D. Celermajer,et al.  Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. , 1993, Journal of the American College of Cardiology.

[9]  J. Stamler,et al.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.

[10]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[11]  M. Malinow,et al.  Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. , 1992, Annual review of nutrition.

[12]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[13]  J. Ubbink,et al.  Vitamin B-6 nutrition status and cigarette smoking. , 1990, The American journal of clinical nutrition.

[14]  M. Malinow.  Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. , 1990, Circulation.

[15]  J. Finkelstein,et al.  Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.

[16]  W. Vermaak,et al.  Inhibition of pyridoxal kinase by methylxanthines. , 1990, Enzyme.

[17]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[18]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[19]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[20]  R. Ross,et al.  Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. , 1983, Circulation research.

[21]  D. Wilcken,et al.  Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine. , 1983, The New England journal of medicine.

[22]  G. Striker,et al.  Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. , 1980, Thrombosis research.